Vical (VICL) Stock: Headed Up On Strategic Options Review

Vical Incorporated (NASDAQ: VICL) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that it intends on exploring strategic options, which proved to be a source of excitement for investors. Today, we’ll talk about: The exploration of strategic options; what we’re … Read more

Vical (VICL) Stock: Falling Hard On Failed Clinical Trial

Vical Incorporated (NASDAQ: VICL) is having an overwhelmingly rough start to the trading session in the pre-market hours this morning, and for good reason. The company announced top-line results from a clinical trial that failed to meet its primary endpoint. Of course, the news struck fear among investors, sending the stock tumbling down. Today, we’ll … Read more

Biotech Stock News (EPZM) (VICL) (ALPMF) (CBLI)

Epizyme (NASDAQ:EPZM) On June 22, 2015 shares of Epizyme were up about 27% after the company announced that it had obtained positive phase 1 results in patients with Non-Hodgkin’s Lymphoma — NHL. The company used its drug known as EPZ-6438, which is also known as tazemetostat to treat these patients with NHL. Epizyme has developed … Read more

Notable Biotech Gainers | RXi Pharmaceuticals (RXII) | Prima Biomed (PBMD) | Amedisys (AMED) | Vical Incorporated (VICL)

Looking in the biotech market today, we’re seeing a sea of red. However, even on the bad days, we tend to see notable gainers. With that said, here are some of the fastest moving gainers in biotech today… RXi Pharmaceuticals Stock Climbs On Notices Of Allowance RXi Pharmaceuticals Corp (NASDAQ: RXII) RXII is having a … Read more